Filing Details
- Accession Number:
- 0001209191-14-038147
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-30 20:00:20
- Reporting Period:
- 2014-05-28
- Filing Date:
- 2014-05-30
- Accepted Time:
- 2014-05-30 20:00:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 858803 | Avanir Pharmaceuticals Inc. | AVNR | Pharmaceutical Preparations (2834) | 330314804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314596 | Keith Katkin | 20 Enterprise, Suite 200 Aliso Viejo CA 92656 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-28 | 442,212 | $5.01 | 750,082 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-05-28 | 75,000 | $0.00 | 75,000 | $1.29 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-05-28 | 317,212 | $0.00 | 317,212 | $0.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,960 | 2017-03-21 | No | 4 | M | Direct | |
| 0 | 2018-07-25 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. A portion of the proceeds from the sales will be used to pay required withholdings due by the Reporting Person. Following the sales reported on this Form 4, the Reporting Person has a total of 1,261,998 options to purchase shares of common stock that are vested and immediately exercisable and a total of 528,593 options to purchase shares of common stock that have not yet vested. Following the sales reported on this Form 4, the Reporting Person also has 605,718 unvested Restricted Stock Units, of which 97,250 are performance-based Restricted Stock Units.
- Represents the weighted-average price at which shares were sold within a range between $5.00 and $5.09. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- Includes previously reported shares of common stock underlying Restricted Stock Grants granted to the Reporting Person, which are subject to certain vesting conditions.
- The option was granted on 3/21/2007 and vested with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.
- The option was granted on 7/25/2008 and vested with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.
Billionaire Hedge Funds
